Florendo, Neil C.

HRN: 25-35-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/28/2024
07/05/2024
IV
500mg
Q8hrs
Enterocutaneous Fistula
Waiting Final Action 
06/28/2024
CEFTRIAXONE 1G (VIAL)
06/28/2024
07/05/2024
IV
2g
Q24
Enterocutaneous Fistula
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: